Clinical trial
Intermediate Expanded Access Protocol With CNM-Au8 for Multiple Sclerosis
NCT04081714 is registered in ClinicalTrials.gov with Clene Nanomedicine as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intermediate Expanded Access Protocol With CNM-Au8 for Multiple Sclerosis
- Lead sponsor
- Clene Nanomedicine
- Phase
- Expanded access
- Overall status
- Temporarily not available
- Start date
- Not reported
- Completion date
- Not reported
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.